Novo Holdings participates in US$65.7 Million Series C Financing in Singapore-based Regional Telehealth Platform Doctor Anywhere
SINGAPORE, Aug. 31, 2021 /PRNewswire/ -- Novo Holdings A/S ("Novo Holdings" and "NH"), a leading international investor in healthcare and life sciences, today announces that it has participated in the US$65.7 million Series C financing in Doctor Anywhere ("DA", "the Company"), a regional tech-led healthcare company headquartered in Singapore.
- SINGAPORE, Aug. 31, 2021 /PRNewswire/ -- Novo Holdings A/S ("Novo Holdings" and "NH"), a leading international investor in healthcare and life sciences, today announces that it has participated in the US$65.7 million Series C financing in Doctor Anywhere ("DA", "the Company"), a regional tech-led healthcare company headquartered in Singapore.
- Since its launch in 2017, DA has grown exponentially to serve more than 1.5 million users in Singapore and the wider region.
- We are thrilled to attract the interest of Novo Holdings, one of the world's leading life sciences investors.
- Novo Holdings A/S is a private limited liability company wholly owned by the Novo Nordisk Foundation.